Dr. Nancy E. Thomas

Patient Experience Rating

(4/5) Patient Experience Rating

Dermatology

General Dermatology

Chapel Hill, NC

UNC Hospitals

21+ Yrs Experience

Dr. Nancy E. Thomas MD

410 Market St , Chapel Hill , NC

Specialties

Subspecialties, patient experience.

Provides clear explanation

Makes time for patients

Listens attentively

Practices at Best Hospital

Provides clear information and answers questions in a way patients understand.

Spends appropriate amount of time with patient and provides thorough examinations.

Rated highly on their manner and listening skills.

This doctor practices at a U.S. News Best Regional Hospital

Overall Patient Experience

Very Positive

8 Reviews Total | 0 Reviews Within Last 12 Months

Thoroughness of Examination

Previous patients' satisfaction in their perception of the thoroughness of the examination they received from this physician

Ability to Answer Questions

Previous patients' assessment of this physician's ability to answer all of their questions

Provider's follow-up

Previous patients' satisfaction of the followup care they received from this physician and responsiveness to their concerns

Amount of Time with Patient

Previous patients' satisfaction with the time this physician spent with them during appointments

Provider's Attitude

Previous patients' assessment of this physician's friendliness and caring attitude

Perceived Outcomes

Previous patients' satisfaction with the physician's treatment of a condition or outcome of a procedure

General Feedback

Previous patients' general assessment of this physician

See All Categories

Areas of expertise for dr. thomas.

This doctor provides the following types of care. The more often a doctor has treated a particular condition or has performed a particular surgery, the more expertise they may have in treating patients with similar needs. Based on three years (2020-2022) of Medicare data, each scale below indicates the volume of episodes compared to other doctors who treat the same condition. Click here to learn more about our methodology.

Benign or precancerous skin growths Benign or precancerous skin growths are non-cancerous growths on the skin that might need monitoring or treatment.

Removal of cancerous skin growth Removal of cancerous skin growth is done to treat skin cancers.

Skin discoloration Skin discoloration can involve changes in skin color due to various factors.

Looking for something else?

Check to See if Dr. Nancy E. Thomas Accepts Your Insurance

Accepts Medicare

Accepts Medicaid

Please contact your provider to confirm if they accept your insurance.

Insurance Carrier

Aetna, Cigna, etc.

Accepted Insurance Plans

Blue Cross Blue Shield of Michigan

CMS Medicare

NC State Medicaid

Regence Health Plans

United Healthcare

Don`t see your plan listed? Click here to find providers that accept your insurance .

Dermatologists Like Dr. Thomas Near Me

David Rubenstein MD

Chapel Hill , NC

Stefan Weiss MD

Stefan Weiss MD

Austin Newsome MD

Mebane , NC

Austin Newsome MD

Luis Diaz-Sr MD

Luis Diaz-Sr MD

Location & Contact Information

Doctor Address

410 Market St, Ste 362, Chapel Hill, NC, 27516

Affiliated Hospitals

Where does Dr. Thomas practice?

Doctor’s office.

University Of North Carolina At Chapel Hill

Here are other providers that practice at the same doctor's office:

Thomas Marsland

Family Medicine

Robert Sandler

Gastroenterology

Jen Jen Yeh

General Surgery

Edith Bowers

Sean McLean

Randal Detwiler

Evan Dellon

Ashley Rietz

Plastic Surgery

Hans Herfarth

Rupali Shah

Otolaryngology (ENT)

Stephen Tilley

Pulmonology

Richard Sutherland

Christine Cleveland

Physical Medicine & Rehabilitation

Robert Buckmire

Sarah Smithson

Internal Medicine

Antonio Rodriguez

Matthew Nielsen

Hospital Affiliations

Unc hospitals chapel hill, nc.

# 2 in North Carolina

Education & Experience

Medical school & residency.

University of Rochester

Residency , Dermatology , 1988 - 1992

Rockefeller University

PhD , Bioorganic Chemistry , 1982 - 1986

Weill Cornell Medicine

Medical School

Internship , Surgery , 1987 - 1988

Certifications & Licensure

American Board of Dermatology

Certified in Dermatology

NC State Medical License

Active through 2025

NY State Medical License

Active through 1992

Awards, Honors & Recognitions

CMS Stage 1 2012 , 2012

Checkbook Top Doc

Publications

Robert C. Millikan: In Memoriam.

Olshan, A. F., Ambrosone, C. B., Barnholtz-Sloan, J. S., Berwick, M., Palmer, J. R., Thomas, N. E.

The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.

Tyler J M Jordan, Jinbo Chen, Ning Li, Susan Burette, Li Wan, Liuqing Chen, Donna A Culton, Songmei Geng, Paul Googe, Nancy E Thomas, Luis A Diaz, Zhi Liu

Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death.

David Corley Gibbs, Nancy E Thomas, Peter A Kanetsky, Li Luo, Klaus J Busam, Anne E Cust, Hoda Anton-Culver, Richard P Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Sharon N Edmiston, Kathleen Conway, David W Ollila, Colin B Begg, Marianne Berwick, Sarah V Ward, Irene Orlow

Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis.

Ivan P Gorlov, Kathleen Conway, Sharon N Edmiston, Eloise A Parrish, Honglin Hao, Christopher I Amos, Spiridon Tsavachidis, Olga Y Gorlova, Colin Begg, Eva Hernando, Chao Cheng, Ronglai Shen, Irene Orlow, Li Luo, Marc S Ernstoff, Pei Fen Kuan, David W Ollila, Yihsuan S Tsai, Marianne Berwick, Nancy E Thomas

Pathway Alterations in Stage II/III Primary Melanoma.

Caroline E Kostrzewa, Li Luo, Arshi Arora, Venkatraman E Seshan, Marc S Ernstoff, Sharon N Edmiston, Kathleen Conway, Ivan Gorlov, Klaus Busam, Irene Orlow, Eva Hernando-Monge, Nancy E Thomas, Marianne Berwick, Colin B Begg, Ronglai Shen

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.

Li Luo, Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J Busam, Cecilia Lezcano, Tim K Lee, Eva Hernando, Ivan Gorlov, Christopher Amos, Marc S Ernstoff, Venkatraman E Seshan, Anne E Cust, James Wilmott, Richard A Scolyer, Graham Mann, Eduardo Nagore, Pauline Funchain, Jennifer Ko, Peter Ngo, Sharon N Edmiston, Kathleen Conway, Paul B Googe, David Ollila, Jeffrey E Lee, Shenying Fang, Judy R Rees, Cheryl L Thompson, Meg Gerstenblith, Marcus Bosenberg, Bonnie Gould Rothberg, Iman Osman, Yvonne Saenger, Adam Z Reynolds, Matthew Schwartz, Tawny Boyce, Sheri Holmen, Elise Brunsgaard, Paul Bogner, Pei Fen Kuan, Charles Wiggins, Nancy E Thomas, Colin B Begg, Marianne Berwick

miRNA Decoy Screen Reveals miR-124a as a Suppressor of Melanoma Metastasis.

Rana S Moubarak, Lisa Koetz-Ploch, Gavriel Mullokandov, Avital Gaziel, Ana de Pablos-Aragoneses, Diana Argibay, Kevin Kleffman, Elena Sokolova, Marianne Berwick, Nancy E Thomas, Iman Osman, Brian D Brown, Eva Hernando

Characterization of the CpG island hypermethylated phenotype (CIMP) subclass in primary melanomas.

Kathleen Conway, Yihsuan S. Tsai, Sharon N. Edmiston, Joel S. Parker, Eloise Parrish, Honglin Hao, Pei Fen Kuan, Glynis Scott, Jill S. Frank, Paul B. Googe, David W. Ollila, Nancy E. Thomas

Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study

Danielle R. Davari, Irene Orlow, Peter A. Kanetsky, Li Luo, Klaus J. Busam, Ajay Sharma, Anne Kricker, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David C. Gibbs, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Disease-Associated Risk Variants in ANRIL are Associated with Tumor-Infiltrating Lymphocytes Presence in Primary Melanomas in the Population-Based GEM Study.

Danielle R. Davari, Irene Orlow, Peter A. Kanetsky, Li Luo, Sharon N. Edmiston, Kathleen Conway, Eloise Parrish, Honglin Hao, Klaus J. Busam, Ajay Sharma, Anne Kricker, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Association of surgical interval and survival among hospital and non-hospital based patients with melanoma in North Carolina

Adewole S. Adamson, Bradford E. Jackson, Christopher D. Baggett, Nancy E. Thomas, Michael Pignone

Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

Joseph Michael Yardman-Frank, Baillie Bronner, Stefano Rosso, Lynn From, Klaus J. Busam, Pamela A. Groben, Paul Tucker, Anne E. Cust, Bruce K. Armstrong, Anne Kricker, Loraine D. Marrett, Hoda Anton-Culver, Stephen B. Gruber, Rick Gallagher, Roberto Zanetti, Lidia Sacchetto, Terry Dwyer, Alison Venn, Irene Orlow, Peter A. Kanetsky, Li Luo, Nancy E. Thomas, Colin B. Begg, Marianne Berwick, Gem Study Team

Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).

Stergios J. Moschos, Zeynep Eroglu, Nikhil I. Khushalani, Kari Kendra, George Ansstas, Gino K. In, Peng Wang, Glenn Liu, Frances A. Collichio, Paul B. Googe, Craig C. Carson, Karen P. McKinnon, Hsing-Hui Wang, Nana Nikolaishvilli-Feinberg, Anastasia Ivanova, Christy Arrowood, Nancy Garrett-Mead, Kathleen Conway, Sharon N. Edmiston, David W. Ollila, Jonathan S. Serody, Nancy E. Thomas, S. Percy Ivy, Lokesh Agrawal, Elizabeth Claire Dees, James L. Abbruzzese

Immunohistochemical Expression of PD-L1 Is Increased in Lesional Epidermal Keratinocytes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Carolyn Ziemer, Jayson Miedema, Collin-Jamal Smith, Zhi Liu, Nancy E. Thomas, Paul B. Googe

Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study.

Joseph Michael Yardman-Frank, Elyssa Glassheim, Anne Kricker, Bruce K. Armstrong, Loraine D. Marrett, Li Luo, Anne E. Cust, Klaus J. Busam, Irene Orlow, Richard P. Gallagher, Stephen B. Gruber, Hoda Anton-Culver, Stefano Rosso, Roberto Zanetti, Lidia Sacchetto, Peter A. Kanetsky, Terence Dwyer, Alison Venn, Julia Lee-Taylor, Colin B. Begg, Nancy E. Thomas, Marianne Berwick

Non-Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice.

Lin Lin, Bin-Jin Hwang, Ning Li, Paul B. Googe, Luis A. Diaz, Edward A. Miao, Barbara J. Vilen, Nancy E. Thomas, Jenny P.-Y. Ting, Zhi Liu

Association of known melanoma risk factors with primary melanoma of the scalp and neck

Renee P. Wood, Jane Heyworth, Nina S. McCarthy, Audrey Mauguen, Marianne Berwick, Nancy E. Thomas, Michael Millward, Hoda Anton-Culver, Anne E. Cust, Terence Dwyer, Richard P. Gallagher, Stephen B. Gruber, Peter A. Kanetsky, Irene Orlow, Stefano Rosso, Eric K. Moses, Colin B. Begg, Sarah V. Ward

Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma

Ivan P. Gorlov, Christopher I. Amos, Spiridon Tsavachidis, Colin B. Begg, Eva Hernando, Chao Cheng, Ronglai Shen, Irene Orlow, Li Luo, Marc S. Ernstoff, Joel S. Parker, Nancy E. Thomas, Olga Y. Gorlova, Marianne Berwick

A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.

Anne E. Cust, Caro-Anne Badcock, Jonathan M. Smith, Nancy E. Thomas, Lauren E. Haydu, Bruce K. Armstrong, Matthew Law, John F. Thompson, P.A. Kanetsky, C. B. Begg, Yang Shi, Anne Kricker, Irene Orlow, Ajay Sharma, Sarah Yoo, Siok Leong, Marianne Berwick, David W. Ollila, Serigne Lo

Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma.

David C. Gibbs, Irene Orlow, Steven Vernali, Helen B. Powell, Peter A. Kanetsky, Li Luo, Klaus J. Busam, Ajay Sharma, Anne Kricker, Bruce K. Armstrong, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

Sarah V. Ward, David C. Gibbs, Irene Orlow, Nancy E. Thomas, P.A. Kanetsky, Li Luo, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Stefano Rosso, R. Zanetti, Terence Dwyer, Colin B. Begg, Marianne Berwick

The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression

Bin-Jin Hwang, Yang Zhang, Jaime M Brozowski, Zhen Liu, Susan Burette, Kendall J. Lough, Christof C. Smith, Yue Shan, Jinbo Chen, Ning Li, Scott E. Williams, Maureen A. Su, Paul B. Googe, Nancy E. Thomas, Zhi Liu

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis

Kathleen Conway, Sharon N. Edmiston, Joel S. Parker, Pei Fen Kuan, Yi-Hsuan Tsai, Pamela A. Groben, Daniel C. Zedek, Glynis Scott, Eloise Parrish, Honglin Hao, Michelle V. Pearlstein, Jill S. Frank, Craig C. Carson, Matthew D. Wilkerson, Xiaobei Zhao, Nathaniel A. Slater, Stergios J. Moschos, David W. Ollila, Nancy E. Thomas

Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma (GEM) Study.

Jonathan A Miles, Irene Orlow, Peter A. Kanetsky, Li Luo, Anne E. Cust, Bruce K. Armstrong, Anne Kricker, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David C. Gibbs, Klaus J. Busam, Vikram Mavinkurve, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Cristina Pellegrini, Francesca Botta, Daniela Massi, Claudia Martorelli, Fabio Facchetti, Sara Gandini, Patrick Maisonneuve, Marie-Françoise Avril, Florence Demenais, Brigitte Bressac-de Paillerets, Veronica Höiom, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Loraine D. Marrett, Roberto Zanetti, Terence Dwyer, Nancy E. Thomas, Colin B. Begg, Marianne Berwick, Susana Puig, Miriam Potrony, Eduardo Nagore, Paola Ghiorzo, Chiara Menin, Ausilia Maria Manganoni, Monica Rodolfo, Sonia Brugnara, Emanuela Passoni, Lidija Kandolf Sekulović, Federica Baldini, Gabriella Guida, Alexandros Stratigos, Fezal Ozdemir, Fabrizio Ayala, Ricardo Fernández-de-Misa, Pietro Quaglino, Gloria Ribas, Antonella Romanini, Emilia Migliano, Ignazio Stanganelli, Peter A. Kanetsky, Maria Antonietta Pizzichetta, José C. García-Borrón, Hongmei Nan, Maria Teresa Landi, Julian Little, Julia Newton-Bishop, Francesco Sera, Maria Concetta Fargnoli, Sara Raimondi, Mauro Alaibac, Andrea Ferrari, Barbara Valeri, Mariacristina Sicher, Daniela Mangiola, Gianluca Nazzaro, Giulio Tosti, Giovanni Mazzarol, Giuseppe Giudice, Simone Ribero, Chiara Astrua, Laura Mazzoni, Irene Orlow, Urvi Mujumdar, Amanda J. Hummer, Klaus J. Busam, Pampa Roy, Rebecca Canchola, Brian A. Clas, Javiar Cotignola, Yvette Monroe, Bruce K. Armstrong, Anne Kricker, Melisa Litchfield, Paul Tucker, Nicola Stephens, Teresa Switzer, Beth Theis, Lynn From, Noori Chowdhury, Louise Vanasse, Mark P. Purdue, David Northrup, Stefano Rosso, Carlotta Sacerdote, Nancy Leighton, Maureen Gildea, Joe Bonner, Joanne Jeter, Judith B. Klotz, Homer Wilcox, Helen A. Weiss, Robert C. Millikan, Dianne Mattingly, Jon Player, Chiu-Kit Tse, Timothy R. Rebbeck, Amy Walker, Saarene Panossian, Richard Setlow, Harvey Mohrenweiser, Philippe Autier, Jiali Han, Saverio Caini, Albert Hofman, Manfred Kayser, Fan Liu, Tamar Nijsten, André G. Uitterlinden, Rajesh Kumar, Tim Bishop, Faye Elliott, DeAnn Lazovich, David Polsky, Johan Hansson, Lorenza Pastorino, Nelleke A. Gruis, Jan Nico Bouwes Bavinck, Paula Aguilera, Celia Badenas, Cristina Carrera, Pol Gimenez-Xavier, Josep Malvehy, Joan Anton Puig-Butille, Gemma Tell-Marti, Leigh Blizzard, Jennifer Cochrane, Wojciech Branicki, Tadeusz Dębniak, Niels Morling, Peter Johansen, Susan T. Mayne, Allen E. Bale, Brenda Cartmel, Leah M. Ferrucci, Ruth M. Pfeiffer, Giuseppe Palmieri, Katerina P. Kypreou, Anne M. Bowcock, Lynn A. Cornelius, Tomonori Motokawa, Sumiko Anno, Per Helsing, Per Arne Andresen, Stefania Guida, Terence H. Wong

Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.

Nancy E. Thomas, Sharon N. Edmiston, Yihsuan S. Tsai, Joel S. Parker, Paul B. Googe, Klaus J. Busam, Glynis Scott, Daniel C. Zedek, Eloise Parrish, Honglin Hao, Nathaniel A. Slater, Michelle V. Pearlstein, Jill S. Frank, Pei Fen Kuan, David W. Ollila, Kathleen Conway

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis

Yanding Zhao, Evelien Schaafsma, Ivan P. Gorlov, Eva Hernando, Nancy E. Thomas, Ronglai Shen, Mary Jo Turk, Marianne Berwick, Christopher I. Amos, Chao Cheng

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Nancy E. Thomas, Sharon N. Edmiston, Irene Orlow, Peter A. Kanetsky, Li Luo, David C. Gibbs, Eloise Parrish, Honglin Hao, Klaus J. Busam, Bruce K. Armstrong, Anne Kricker, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David W. Ollila, Colin B. Begg, Marianne Berwick, Kathleen Conway

Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes

Kim T. Vuong, Jennifer S. Walker, Helen B. Powell, Nancy E. Thomas, Daniel E Jonas, Adewole S. Adamson

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival

Irene Orlow, Yang Shi, Peter A. Kanetsky, Nancy E. Thomas, Li Luo, Sergio Corrales-Guerrero, Anne E. Cust, Lidia Sacchetto, Roberto Zanetti, Stefano Rosso, Bruce K. Armstrong, Terence Dwyer, Alison Venn, Richard P. Gallagher, Stephen B. Gruber, Loraine D. Marrett, Hoda Anton-Culver, Klaus J. Busam, Colin B. Begg, Marianne Berwick

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Nancy E. Thomas, Sharon N. Edmiston, Peter A. Kanetsky, Klaus J. Busam, Anne Kricker, Bruce K. Armstrong, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Li Luo, Irene Orlow, Anne S. Reiner, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, Eloise Parrish, Honglin Hao, David C. Gibbs, Jill S. Frank, David W. Ollila, Colin B. Begg, Marianne Berwick, Kathleen Conway

Association of Delays in Surgery for Melanoma With Insurance Type.

Adewole S. Adamson, Lei Zhou, Christopher D. Baggett, Nancy E. Thomas, Anne Marie Meyer

Functional melanoma‐risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas

David C. Gibbs, Sarah V. Ward, Irene Orlow, Gemma Cadby, P.A. Kanetsky, Li Luo, Klaus J. Busam, Anne Kricker, Bruce K. Armstrong, Anne E. Cust, Hoda Anton-Culver, Richard P. Gallagher, R. Zanetti, Stefano Rosso, Lidia Sacchetto, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Steven Vernali, Weston T. Waxweiler, Patrick M. Dillon, Peter A. Kanetsky, Irene Orlow, Li Luo, Klaus J. Busam, Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, Anne E. Cust, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

A PGC1β genetic variant associated with nevus count and melanoma mortality

Xin Li, Hongliang Liu, Christopher I. Amos, Jeffrey E. Lee, Nancy E. Thomas, Qingyi Wei, Jiali Han

Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients.

Shachar Laks, Michael O. Meyers, Allison M. Deal, Jill S. Frank, Karyn B. Stitzenberg, Jen Jen Yeh, Nancy E. Thomas, David W. Ollila

No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study.

E. Schwitzer, Irene Orlow, Emily C. Zabor, Colin B. Begg, Marianne Berwick, Nancy E. Thomas, Peter A. Kanetsky, Lee W. Jones

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Audrey Mauguen, Emily C. Zabor, Nancy E. Thomas, Marianne Berwick, Venkatraman E. Seshan, Colin B. Begg

No prognostic value added by Vitamin D pathway SNPs to current prognostic system for melanoma survival

Li Luo, Irene Orlow, Peter A. Kanetsky, Nancy E. Thomas, Shenying Fang, Jeffrey E. Lee, Marianne Berwick, Ji-Hyun Lee

A longitudinal test of the Comprehensive Indoor Tanning Expectations Scale: The importance of affective beliefs in predicting indoor tanning behavior

Jessica Gall Myrick, Seth M. Noar, Dannielle E. Kelley, Alexandra Zeitany, Brenda Morales-Pico, Nancy E. Thomas

Variants in autophagy‐related genes and clinical characteristics in melanoma: a population‐based study

Kirsten White, Li Luo, Todd A. Thompson, Salina M. Torres, Chien-An Andy Hu, Nancy E. Thomas, Jenna Lilyquist, Hoda Anton-Culver, Stephen B. Gruber, Lynn From, Klaus J. Busam, Irene Orlow, Peter A. Kanetsky, Loraine D. Marrett, Richard P. Gallagher, Lidia Sacchetto, Stefano Rosso, Terence Dwyer, Anne E. Cust, Colin B. Begg, Marianne Berwick

ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma

Meagan B. Ryan, Alexander J. Finn, Katherine H. Pedone, Nancy E. Thomas, Channing J. Der, Adrienne D. Cox

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Nicholas J. Taylor, Nancy E. Thomas, Hoda Anton-Culver, Bruce K. Armstrong, Colin B. Begg, Klaus J. Busam, Anne E. Cust, Terence Dwyer, Lynn From, Richard P. Gallagher, Stephen B. Gruber, Diane E. Nishri, Irene Orlow, Stefano Rosso, Alison Venn, Roberto Zanetti, Marianne Berwick, Peter A. Kanetsky

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways

David C. Gibbs, Irene Orlow, Jennifer I. Bramson, Peter A. Kanetsky, Li Luo, Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Loraine D. Marrett, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Terence Dwyer, Ajay Sharma, Emily La Pilla, Lynn From, Klaus J. Busam, Anne E. Cust, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

The state of melanoma: challenges and opportunities

Glenn Merlino, Meenhard Herlyn, David E. Fisher, Boris C. Bastian, Keith T. Flaherty, Michael A. Davies, Jennifer A. Wargo, Clara Curiel-Lewandrowski, Michael J. Weber, Sancy A. Leachman, Maria S. Soengas, Martin McMahon, J. William Harbour, Susan M. Swetter, Andrew E. Aplin, Michael B. Atkins, Marcus Bosenberg, Reinhard Dummer, Jeffrey E. Gershenwald, Allan C. Halpern, Dorothee Herlyn, Giorgos C. Karakousis, John M. Kirkwood, Michael Krauthammer, Roger S. Lo, Georgina V. Long, Grant A. McArthur, Antoni Ribas, Lynn M. Schuchter, Jeffrey A. Sosman, Keiran S.M. Smalley, Patricia S. Steeg, Nancy E. Thomas, Hensin Tsao, Thomas Tueting, Ashani T. Weeraratna, George Xu, Randy Lomax, Alison Martin, Steve Silverstein, Tim Turnham, Ze'ev Ronai

An Empirical Analysis of Indoor Tanners: Implications for Audience Segmentation in Campaigns

Dannielle E. Kelley, Seth M. Noar, Jessica Gall Myrick, Brenda Morales-Pico, Alexandra Zeitany, Nancy E. Thomas

Melanoma Epidemiology and Prevention.

Marianne Berwick, David B. Buller, Anne E. Cust, Richard P. Gallagher, Tim K. Lee, Frank L. Meyskens, Shaily Pandey, Nancy E. Thomas, Marit B. Veierød, Sarah V. Ward

Effective Intra‐S Checkpoint Responses to UVC in Primary Human Melanocytes and Melanoma Cell Lines

Marila Cordeiro-Stone, John J. McNulty, Christopher D. Sproul, Paul D. Chastain, Eugene A. Gibbs-Flournoy, Yingchun Zhou, Craig C. Carson, Shangbang Rao, David L. Mitchell, Dennis A. Simpson, Nancy E. Thomas, Joseph G. Ibrahim, William K. Kaufmann

Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.

Irene Orlow, Anne S Reiner, Nancy E Thomas, Pampa Roy, Peter A Kanetsky, Li Luo, Susan Paine, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Stefano Rosso, Roberto Zanetti, Stephen B Gruber, Hoda Anton-Culver, Richard P Gallagher, Terence Dwyer, Klaus Busam, Colin B Begg, Marianne Berwick

Appearance normalization of histology slides

Jared Vicory, Heather D. Couture, Nancy E. Thomas, David Borland, James Stephen Marron, John T. Woosley, Marc Niethammer

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Nancy E. Thomas, Sharon N. Edmiston, Audrey Alexander, Pamela A. Groben, Eloise Parrish, Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Lynn From, Klaus J. Busam, Honglin Hao, Irene Orlow, Peter A. Kanetsky, Li Luo, Anne S. Reiner, Susan Paine, Jill S. Frank, Jennifer I. Bramson, Lorraine D. Marrett, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Terence Dwyer, Anne E. Cust, David W. Ollila, Colin B. Begg, Marianne Berwick, Kathleen Conway

Inherited variation at MC1R and ASIP and association with melanoma-specific survival.

Nicholas J. Taylor, Anne S. Reiner, Colin B. Begg, Anne E. Cust, Klaus J. Busam, Hoda Anton-Culver, Terence Dwyer, Lynn From, Richard P. Gallagher, Stephen B. Gruber, Stefano Rosso, Kirsten White, Roberto Zanetti, Irene Orlow, Nancy E. Thomas, Timothy R. Rebbeck, Marianne Berwick, Peter A. Kanetsky

Error in Text. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Craig C. Carson, Stergios J. Moschos, Sharon N. Edmiston, David B. Darr, Nana Nikolaishvili-Feinberg, Pamela A. Groben, Xin Zhou, Pei Fen Kuan, Shaily Pandey, Keefe T. Chan, Jamie L. Jordan, Honglin Hao, Jill S. Frank, Dennis A. Hopkinson, David C. Gibbs, Virginia D. Alldredge, Eloise Parrish, Sara C. Hanna, Paula Berkowitz, David S. Rubenstein, C. Ryan Miller, James E. Bear, David W. Ollila, Norman E. Sharpless, Kathleen Conway, Nancy E. Thomas

Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma

David C. Gibbs, Irene Orlow, Peter A. Kanetsky, Li Luo, Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Loraine D. Marrett, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Terence Dwyer, Ajay Sharma, Emily La Pilla, Lynn From, Klaus J. Busam, Anne E. Cust, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Inherited variation at MC1R and histological characteristics of primary melanoma.

Nicholas J. Taylor, Klaus J. Busam, Lynn From, Pamela A. Groben, Hoda Anton-Culver, Anne E. Cust, Colin B. Begg, Terence Dwyer, Richard P. Gallagher, Stephen B. Gruber, Irene Orlow, Stefano Rosso, Nancy E. Thomas, Roberto Zanetti, Timothy R. Rebbeck, Marianne Berwick, Peter A. Kanetsky

Testing a social cognitive theory-based model of indoor tanning: implications for skin cancer prevention messages.

Seth M. Noar, Jessica Gall Myrick, Alexandra Zeitany, Brenda Morales-Pico, Nancy E. Thomas

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study

Nancy E. Thomas, Anne Kricker, Weston T. Waxweiler, Patrick M. Dillon, Klaus J. Busam, Lynn From, Pamela A. Groben, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Loraine D. Marrett, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Terence Dwyer, Alison Venn, Peter A. Kanetsky, Irene Orlow, Susan Paine, David W. Ollila, Anne S. Reiner, Li Luo, Honglin Hao, Jill S. Frank, Colin B. Begg, Marianne Berwick

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Nancy E. Thomas, Nathaniel A. Slater, Sharon N. Edmiston, Xin Zhou, Pei Fen Kuan, Pamela A. Groben, Craig C. Carson, Honglin Hao, Eloise Parrish, Stergios J. Moschos, Marianne Berwick, David W. Ollila, Kathleen Conway

Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.

Michelle V. Pearlstein, Daniel C. Zedek, David W. Ollila, Amanda L. Treece, Margaret L. Gulley, Pamela A. Groben, Nancy E. Thomas

Sun Exposure and Melanoma Survival: A GEM Study

Marianne Berwick, Anne S. Reiner, Susan Paine, Bruce K. Armstrong, Anne Kricker, Chris Goumas, Anne E. Cust, Nancy E. Thomas, Pamela A. Groben, Lynn From, Klaus J. Busam, Irene Orlow, Loraine D. Marrett, Richard P. Gallagher, Stephen B. Gruber, Hoda Anton-Culver, Stefano Rosso, Roberto Zanetti, Peter A. Kanetsky, Terry Dwyer, Alison Venn, Julia Lee-Taylor, Colin B. Begg

Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.

William R. Jeck, Joel S. Parker, Craig C. Carson, Janiel M. Shields, Maria J. Sambade, Eldon C. Peters, Christin E. Burd, Nancy E. Thomas, Derek Y. Chiang, Wenjin Liu, David A. Eberhard, David W. Ollila, Juneko E. Grilley-Olson, Stergios J. Moschos, D. Neil Hayes, Norman E. Sharpless

Mechanisms of chromosomal instability in melanoma

William K. Kaufmann, Craig C. Carson, Bernard Omolo, Adam J. Filgo, Maria J. Sambade, Dennis A. Simpson, Janiel M. Shields, Joseph G. Ibrahim, Nancy E. Thomas

MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors

Marianne Berwick, Jamie MacArthur, Irene Orlow, Peter A. Kanetsky, Colin B. Begg, Li Luo, Anne S. Reiner, Ajay Sharma, Bruce K. Armstrong, Anne Kricker, Anne E. Cust, Loraine D. Marrett, Stephen B. Gruber, Hoda Anton-Culver, Roberto Zanetti, Stefano Rosso, Richard P. Gallagher, Terrance Dwyer, Alison Venn, Klaus J. Busam, Lynn From, Kirsten White, Nancy E. Thomas

Development and validation of the Comprehensive Indoor Tanning Expectations Scale.

Seth M. Noar, Brenda Morales-Pico, Nancy E. Thomas

Development of DNA Damage Response Signaling Biomarkers using Automated, Quantitative Image Analysis

Nana Nikolaishvilli-Feinberg, Stephanie M. Cohen, Bentley R. Midkiff, Yingchun Zhou, Mark Olorvida, Joseph G. Ibrahim, Bernard Omolo, Janiel M. Shields, Nancy E. Thomas, Pamela A. Groben, William K. Kaufmann, Christopher Ryan Miller

SOLAR ULTRAVIOLET EXPOSURE AND MORTALITY FROM SKIN TUMORS

Marianne Berwick, Claire R Pestak, Nancy E. Thomas

Occupational sun exposure and risk of melanoma according to anatomical site.

Vuong K, McGeechan K, Armstrong BK, AMFS Investigators, GEM Investigators, Cust AE

Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study

Nancy E. Thomas, Klaus J. Busam, Lynn From, Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Terence Dwyer, Alison Venn, Peter A. Kanetsky, Pamela A. Groben, Honglin Hao, Irene Orlow, Anne S. Reiner, Li Luo, Susan Paine, David W. Ollila, Homer Wilcox, Colin B. Begg, Marianne Berwick

Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.

Anne Kricker, Bruce K. Armstrong, Chris Goumas, Nancy E. Thomas, Lynn From, Klaus J. Busam, Peter A. Kanetsky, Richard P. Gallagher, Loraine D. Marrett, Pamela A. Groben, Stephen B. Gruber, Hoda Anton-Culver, Stefano Rosso, Terence Dwyer, Marianne Berwick

Leveraging Epidemiology and Clinical Studies of Cancer Outcomes: Recommendations and Opportunities for Translational Research

Joanne W. Elena, Lois B. Travis, Naoko I. Simonds, Christine B. Ambrosone, Rachel Ballard-Barbash, Smita Bhatia, James R. Cerhan, Patricia Hartge, Rebecca S. Heist, Lawrence H. Kushi, Timothy L. Lash, Lindsay M. Morton, Kenan Onel, John P. Pierce, Leslie L. Robison, Julia H. Rowland, Deborah Schrag, Thomas A. Sellers, Daniela Seminara, Xiao-Ou Shu, Nancy E. Thomas, Cornelia M. Ulrich, Andrew N. Freedman

Skin Cancer Knowledge and Skin Self-examinations in the Hispanic Population of North Carolina: The Patient's Perspective

Carly J. Roman, Aida Lugo-Somolinos, Nancy E. Thomas

Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas

Rajmohan Murali, Chris Goumas, Anne Kricker, Lynn From, Klaus J. Busam, Colin B. Begg, Terence Dwyer, Stephen B. Gruber, Peter A. Kanetsky, Irene Orlow, Stefano Rosso, Nancy E. Thomas, Marianne Berwick, Richard A. Scolyer, Bruce K. Armstrong

Image and statistical analysis of melanocytic histology

Jayson Miedema, James Stephen Marron, Marc Niethammer, David Borland, John T. Woosley, Jason Coposky, Susan Wei, Howard M Reisner, Nancy E. Thomas

A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines

Craig C. Carson, Bernard Omolo, Haitao Chu, Yingchun Zhou, Maria J. Sambade, Eldon C. Peters, Patrick Tompkins, Dennis A. Simpson, Nancy E. Thomas, Cheng Fan, Alain Sarasin, Philippe Dessen, Janiel M. Shields, Joseph G. Ibrahim, William K. Kaufmann

LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma

Wenjin Liu, Kimberly B. Monahan, Adam D. Pfefferle, Takeshi Shimamura, Jessica A. Sorrentino, Keefe T. Chan, David W. Roadcap, David W. Ollila, Nancy E. Thomas, Diego H. Castrillon, C. Ryan Miller, Charles M. Perou, Kwok-Kin Wong, James E. Bear, Norman E. Sharpless

The TBX21 transcription factor T-1993C polymorphism is associated with decreased IFN-γ and IL-4 production by primary human lymphocytes

K.M. Fyall, A.M. Fong, Shangbang Rao, J.G. Ibrahim, W.T. Waxweiler, Nancy E. Thomas

Vitamin D receptor polymorphisms in patients with cutaneous melanoma

Irene Orlow, Pampa Roy, Anne S. Reiner, Sarah Yoo, Himali Patel, Susan Paine, Bruce K. Armstrong, Anne Kricker, Loraine D. Marrett, Robert C. Millikan, Nancy E. Thomas, Stephen B. Gruber, Hoda Anton-Culver, Stefano Rosso, Richard P. Gallagher, Terence Dwyer, Peter A. Kanetsky, Klaus J. Busam, Lynn From, Colin B. Begg, Marianne Berwick

Sun Exposure, Vitamin D Receptor Polymorphisms FokI and BsmI and Risk of Multiple Primary Melanoma

Rochelle L. Mandelcorn-Monson, Loraine D. Marrett, Anne Kricker, Bruce K. Armstrong, Irene Orlow, Chris Goumas, Susan Paine, Stefano Rosso, Nancy E. Thomas, Robert C. Millikan, Jason D. Pole, Javier Cotignola, Cheryl F. Rosen, Peter A. Kanetsky, Julia Lee-Taylor, Colin B. Begg, Marianne Berwick

Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population

Marianne Berwick, Colin B. Begg, Bruce K. Armstrong, Anne S. Reiner, Nancy E. Thomas, Linda S. Cook, Irene Orlow, Anne Kricker, Loraine D. Marrett, Stephen B. Gruber, Hoda Anton-Culver, Robert C. Millikan, Richard P. Gallagher, Terry Dwyer, Stefano Rosso, Peter A. Kanetsky, Julia Lee-Taylor

P-Rex1 is required for efficient melanoblast migration and melanoma metastasis

Colin R Lindsay, Samuel Lawn, Andrew D. Campbell, William J. Faller, Florian Rambow, Richard L. Mort, Paul Timpson, Ang Li, Patrizia Cammareri, Rachel A. Ridgway, Jennifer P. Morton, Brendan Doyle, Shauna Hegarty, Mairin Rafferty, Ian G. Murphy, Enda W. McDermott, Kieran Sheahan, Katherine H. Pedone, Alexander J. Finn, Pamela A. Groben, Nancy E. Thomas, Honglin Hao, Craig C. Carson, Jim C. Norman, Laura M. Machesky, William M. Gallagher, Ian J. Jackson, Léon C van Kempen, Friedrich Beermann, Channing J. Der, Lionel Larue, Heidi C.E. Welch, Brad Ozanne, Owen J. Sansom

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

Kathleen Conway, Sharon N. Edmiston, Zakaria S. Khondker, Pamela A. Groben, Xin Zhou, Haitao Chu, Pei Fen Kuan, Honglin Hao, Craig C. Carson, Marianne Berwick, David W Olilla, Nancy E. Thomas

Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032

Maria J. Sambade, Eldon C. Peters, Nancy E. Thomas, William K. Kaufmann, Randall J. Kimple, Janiel M. Shields

Secular trends in established and novel cardiovascular risk factors in Welsh 12-13 year olds: A comparison between 2002 and 2007

N.E. Thomas, M.A. Jasper, D. R. R. Williams, David A. Rowe, Robert M. Malina, Bruce Davies, Shannon R. Siegel, Julien S. Baker

Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.

Patrick M. Dillon, Nancy E. Thomas, Norman E. Sharpless, Frances A. Collichio

Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis

Nancy E. Thomas, Anne Kricker, Lynn From, Klaus Busam, Robert C. Millikan, Mary E. Ritchey, Bruce K. Armstrong, Julia Lee-Taylor, Loraine D. Marrett, Hoda Anton-Culver, Roberto Zanetti, Stefano Rosso, Richard P. Gallagher, Terence Dwyer, Chris Goumas, Peter A. Kanetsky, Colin B. Begg, Irene Orlow, Homer Wilcox, Susan Paine, Marianne Berwick

Marc Niethammer, David Borland, James Stephen Marron, John T. Woosley, Nancy E. Thomas

MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.

Anne Kricker, Bruce K. Armstrong, Chris Goumas, Peter A. Kanetsky, Richard P. Gallagher, Colin B. Begg, Robert C. Millikan, Terence Dwyer, Stefano Rosso, Loraine D. Marrett, Nancy E. Thomas, Marianne Berwick

Relationship between Germline MC1R Variants and BRAF-Mutant Melanoma in a North Carolina Population-Based Study

Nancy E. Thomas, Peter A. Kanetsky, Sharon N. Edmiston, Audrey Alexander, Colin B. Begg, Pamela A. Groben, Honglin Hao, Klaus J. Busam, David W. Ollila, Marianne Berwick, Kathleen Conway

Melanoma Molecular Subtypes: Unifying and Paradoxical Results

Nancy E. Thomas, Peter A. Kanetsky, Colin B. Begg, Kathleen Conway, Marianne Berwick

Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Irene Orlow, Diana Tommasi, Bradley Bloom, Irina Ostrovnaya, Javier Cotignola, Urvi Mujumdar, Klaus J. Busam, Achim A. Jungbluth, Richard A. Scolyer, John F. Thompson, Bruce K. Armstrong, Marianne Berwick, Nancy E. Thomas, Colin B. Begg

Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human aging

Yan Liu, Hanna K. Sanoff, Hyunsoon Cho, Christin E. Burd, Chad Torrice, Joseph G. Ibrahim, Nancy E. Thomas, Norman E. Sharpless

INK4/ARF Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to Atherosclerosis

Yan Liu, Hanna K. Sanoff, Hyunsoon Cho, Christin E. Burd, Chad Torrice, Karen L. Mohlke, Joseph G. Ibrahim, Nancy E. Thomas, Norman E. Sharpless

Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.

Anne M. Lachiewicz, Marianne Berwick, Charles L. Wiggins, Nancy E. Thomas

Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program (Journal of Investigative Dermatology (2008) 128, (243-245) DOI: 10.1038/sj.jid.5701028)

Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program.

Anne M Lachiewicz, Marianne Berwick, Charles L Wiggins, Nancy E Thomas

Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression

William K. Kaufmann, Kathleen R. Nevis, Pingping Qu, Joseph G. Ibrahim, Tong Zhou, Yingchun Zhou, Dennis A. Simpson, Jennifer Helms-Deaton, Marila Cordeiro-Stone, Dominic T. Moore, Nancy E. Thomas, Honglin Hao, Zhi Liu, Janiel M. Shields, Glynis Scott, Norman E. Sharpless

Solar UV exposure and mortality from skin tumors.

Marianne Berwick, Anne M. Lachiewicz, Claire R Pestak, Nancy E. Thomas

CD200 is induced by ERK and is a potential therapeutic target in melanoma

Kimberly B. Petermann, Gabriela I. Rozenberg, Daniel C. Zedek, Pamela A. Groben, Karen P. McKinnon, Christin Buehler, William Y. Kim, Janiel M. Shields, Shannon N. Penland, James E. Bear, Nancy E. Thomas, Jonathan S. Serody, Norman E. Sharpless

Consumption of the epidermis: A criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing Breslow depth and ulceration

Ruth F Walters, Pamela A. Groben, Klaus J. Busam, Robert C. Millikan, Harold S. Rabinovitz, Armand B. Cognetta, Martin C. Mihm, Victor G. Prieto, Paul B. Googe, Roy King, Dominic T. Moore, John T. Woosley, Nancy E. Thomas

Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth

Honglin Hao, Vanessa M. Muniz-Medina, Heena Mehta, Nancy E. Thomas, Vladimir Khazak, Channing J. Der, Janiel M. Shields

Distance to diagnosing provider as a measure of access for patients with melanoma.

Karyn B. Stitzenberg, Nancy E. Thomas, Kathleen Dalton, Sarah E. Brier, David W. Ollila, Marianne Berwick, Dianne Mattingly, Robert C. Millikan

Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Nancy E. Thomas, Sharon N. Edmiston, Audrey Alexander, Robert C. Millikan, Pamela A. Groben, Honglin Hao, Dawn Tolbert, Marianne Berwick, Klaus J. Busam, Colin B. Begg, Dianne Mattingly, David W. Ollila, Chiu Kit Tse, Amanda J. Hummer, Julia Lee-Taylor, Kathleen Conway

Eruptive Post‐Chemotherapy In Situ Melanomas and Dysplastic Nevi

Jason C. Reutter, Erin M. Long, Dean S. Morrell, Nancy E. Thomas, Pamela A. Groben

Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma

Janiel M. Shields, Nancy E. Thomas, Melissa A. Cregger, Aaron Berger, Michael C. Leslie, Chad Torrice, Honglin Hao, Shannon N. Penland, Jack L. Arbiser, Glynis Scott, Tong Zhou, Menashe Bar-Eli, James E. Bear, Channing J. Der, William K. Kaufmann, David L. Rimm, Norman E. Sharpless

RNA expression analysis of formalin-fixed paraffin-embedded tumors.

Shannon K. Penland, Temitope O. Keku, Chad Torrice, Xiaping He, Janakiraman Krishnamurthy, Katherine A. Hoadley, John T. Woosley, Nancy E. Thomas, Charles M. Perou, Robert S. Sandler, Norman E. Sharpless

Influence of provider and practice characteristics on melanoma care

Karyn B. Stitzenberg, Nancy E. Thomas, David W. Ollila

Ambient UV, personal sun exposure and risk of multiple primary melanomas

Anne Kricker, Bruce K. Armstrong, Chris Goumas, Melisa Litchfield, Colin B. Begg, Amanda J. Hummer, Loraine D. Marrett, Beth Theis, Robert C. Millikan, Nancy E. Thomas, Hoda Anton Culver, Richard P. Gallagher, Terence Dwyer, Timothy R. Rebbeck, Peter A. Kanetsky, Klaus J. Busam, Lynn From, Urvi Mujumdar, Roberto Zanetti, Marianne Berwick

Muir-Torre Syndrome

Anne M. Lachiewicz, Todd M. Wilkinson, Pamela A. Groben, David W. Ollila, Nancy E. Thomas

Treatment of gefitinib-associated folliculitis

Patricia Matheis, Mark A. Socinski, Craig N. Burkhart, Simon Warren, Nancy E. Thomas

Could BRAF Mutations in Melanocytic Lesions Arise from DNA Damage Induced by Ultraviolet Radiation

Nancy E. Thomas, Marianne Berwick, Marila Cordeiro-Stone

BRAF and NRAS mutations in melanoma and melanocytic nevi.

Jenny N. Poynter, James T. Elder, Douglas R. Fullen, Rajan P. Nair, Maria S. Soengas, Timothy M. Johnson, Bruce G. Redman, Nancy E. Thomas, Stephen B. Gruber

BRAF somatic mutations in malignant melanoma and melanocytic naevi.

Nancy E. Thomas

Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study

Robert C. Millikan, Amanda J. Hummer, Colin B. Begg, Jon Player, Allan René de Cotret, Scott Winkel, Harvey Mohrenweiser, Nancy E. Thomas, Bruce K. Armstrong, Anne Kricker, Loraine D. Marrett, Stephen B. Gruber, Hoda Anton Culver, Roberto Zanetti, Richard P. Gallagher, Terence Dwyer, Timothy R. Rebbeck, Klaus J. Busam, Lynn From, Urvi Mujumdar, Marianne Berwick

Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma.

Karyn B. Stitzenberg, Nancy E. Thomas, Laura M. Beskow, David W. Ollila

Indications for Lymphatic Mapping and Sentinel Lymphadenectomy in Patients with Thin Melanoma (Breslow Thickness ≤1.0 mm)

Karyn B. Stitzenberg, Pamela A. Groben, Stacey L. Stern, Nancy E. Thomas, Thomas A. Hensing, Leah B. Sansbury, David W. Ollila

Invasive superficial spreading melanomas arising from clinically normal skin.

Nancy E. Thomas, Pamela A. Groben

Tandem BRAF mutations in primary invasive melanomas.

Nancy E. Thomas, Audrey Alexander, Sharon N. Edmiston, Eloise Parrish, Robert C. Millikan, Marianne Berwick, Pamela A. Groben, David W. Ollila, Dianne Mattingly, Kathleen Conway

Correlates of recent suicide attempts in a triethnic group of adolescents.

Lynn Rew, Nancy Thomas, Sharon D. Horner, Michael D. Resnick, Trisha Beuhring

The human brain homeogene, DLX-2: cDNA sequence and alignment with the murine homologue.

Daniel J. Selski, Nancy E. Thomas, Paul D. Coleman, Kathryn Rogers

Conformation of Leu-Arg-Arg-Ala-Ser-Leu-Gly Bound in the Active Site of Adenosine Cyclic 3’,5’-Phosphate Dependent Protein Kinase

Bramson Hn, Nancy E. Thomas, W T Miller, Fry Dc, Albert S. Mildvan, Emil Thomas Kaiser

Role of enzyme-peptide substrate backbone hydrogen bonding in determining protein kinase substrate specificities

Nancy E. Thomas, Bramson Hn, W T Miller, Emil Thomas Kaiser

Distinguishing among protein kinases by substrate specificities.

Nancy E. Thomas, Bramson Hn, Angus C. Nairn, Paul Greengard, Fry Dc, Albert S. Mildvan, E. T. Kaiser

The use of N-methylated peptides and depsipeptides to probe the binding of heptapeptide substrates to cAMP-dependent protein kinase.

Bramson Hn, Nancy E. Thomas, E T Kaiser

An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity

Roman Herrera, Lilli Petruzzelli, Nancy E. Thomas, Bramson Hn, E. T. Kaiser, Ora M. Rosen

Modification of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity labels related to peptide substrates.

Bramson Hn, Nancy E. Thomas, R. Matsueda, N. C. Nelson, Susan S. Taylor, E. T. Kaiser

[LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs

Richard K. Assoian, Nancy E. Thomas, E. T. Kaiser, Howard S. Tager

Nuclear magnetic resonance studies of the conformation and kinetics of the peptide-substrate at the active site of bovine heart protein kinase.

Joseph Granot, Albert S. Mildvan, H. Neal Bramson, Nancy E. Thomas, E. T. Kaiser

Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin

Howard S. Tager, Nancy E. Thomas, Richard K. Assoian, Arthur H. Rubenstein, Mark Saekow, Jerrold M. Olefsky, E. T. Kaiser

Frequently Asked Questions About Dr. Thomas

Can i make an appointment online with dr. thomas , does dr. thomas offer telehealth, what do patients say about dr. thomas , dr. thomas accepts insurance, where is dr. thomas' office located, what are dr. thomas' areas of care.

Let us know if this information is out of date or incorrect.

Are you Dr. Nancy E. Thomas ?

nancy e. thomas md phd chapel hill reviews

Living Well With

nancy e. thomas md phd chapel hill reviews

Tips for Relieving Daily Stress and Calming Down

nancy e. thomas md phd chapel hill reviews

Best Immunity Boosters

nancy e. thomas md phd chapel hill reviews

8 Incredibly Heart-Healthy Foods

nancy e. thomas md phd chapel hill reviews

Living With Psoriasis

health disclaimer »

Disclaimer and a note about your health », you may also like, medicare costs to expect.

Elaine Hinzey and Elaine K. Howley Feb. 21, 2024

nancy e. thomas md phd chapel hill reviews

Does Medicare Cover SilverSneakers?

Elaine K. Howley Feb. 16, 2024

nancy e. thomas md phd chapel hill reviews

Medicare Grocery Allowance: What to Know

nancy e. thomas md phd chapel hill reviews

What Is Insulin and What Does Insulin Do?

Elaine K. Howley and Vanessa Caceres Feb. 16, 2024

nancy e. thomas md phd chapel hill reviews

Medicare vs. Medicare Advantage

David Levine and Paul Wynn Feb. 15, 2024

nancy e. thomas md phd chapel hill reviews

Physician Survey Gets Underway

Ben Harder Feb. 15, 2024

nancy e. thomas md phd chapel hill reviews

What Is a Medicare Flex Card?

Elaine K. Howley Feb. 14, 2024

nancy e. thomas md phd chapel hill reviews

Medicare Plan F vs. Plan G

Vanessa Caceres Feb. 13, 2024

nancy e. thomas md phd chapel hill reviews

What to Know About Medicare Part D

Elaine K. Howley Feb. 12, 2024

nancy e. thomas md phd chapel hill reviews

Questions to Ask Your Doctor

Christine Comizio and Lisa Esposito Feb. 12, 2024

nancy e. thomas md phd chapel hill reviews

Dr. Nancy E. Thomas, MD, PhD

Dr. Nancy E. Thomas, MD, PhD

30  Years of Experience

connect with DR. Thomas

UNC Dermatology and Skin Cancer Center at Southern Village

410 Market St., Chapel Hill, NC 27516

Medical Specialties and Areas of Expertise

Dermatologist (Skin Specialist)

Education & Training

Strong Mem Hsp U Rochester, Dermatology; Strong Mem Hsp U Rochester, General Surgery ( Residency )

Strong Memorial Hospital, Surgery, NY, USA (1988) ( Internship )

Strong Memorial Hospital, Rochester, NY, General Surgery ( Internship )

University of Rochester, Rochester, NY, Dermatology ( Fellowship )

Strong Memorial Hospital, Dermatology, NY, USA ( Fellowship )

Board Certifications

American Board of Dermatology

American Board of Dermatology since 2010

American Board of Dermatology since 1992

Medical Conditions Treated

conditions treated by a Dermatologist (Skin Specialist), like Dr. Nancy Thomas, may include:

Please contact Dr. Thomas' office for more information or to schedule a consultation.

Medical Procedures Performed

procedures performed by a Dermatologist (Skin Specialist), like Dr. Nancy Thomas, may include:

For detailed information, please contact Dr. Thomas' office.

Please contact Dr. Thomas ' office to confirm accepted insurance plans.

410 Market St.

Chapel Hill , NC 27516

(984) 974-3900

Get Directions

Recognitions

Memberships & associations.

Society of Investigative Dermatology

American Academy of Dermatology

North Carolina Dermatology Association

AAD Membership

Frequently Asked Questions

Is nancy thomas accepting new patients, does nancy thomas offer online booking, does nancy thomas offer telehealth appointments, which language(s) does nancy thomas speak, which board certifications does nancy thomas have, other dermatologist (skin specialist) near chapel hill, nc.

Dr. Aida Lugo-Somolinos, MD

Dr. Aida Lugo-Somolinos, MD

Dr. David S. Rubenstein, MDPHD

Dr. David S. Rubenstein, MDPHD

Dr. Rajat Varma, MD

Dr. Rajat Varma, MD

Doctors by category.

Specialists

  • UNC Chapel Hill

Department of Dermatology

Make a Gift

Make a Gift Make an Appointment

Nancy Thomas, MD, PhD Laboratories

Dr. Thomas’ research lab focuses on melanoma and non-melanoma skin cancers. Studies described are carried out in the laboratories of Dr. Nancy Thomas and her collaborators in the Melanoma Multidisciplinary Group at UNC and the Genes, Environment, and Melanoma Group (GEM). The UNC Melanoma Group includes clinicians and basic scientists who are working on melanoma. The science is crosscutting and highly collaborative. The research studies are supported by grants from the National Cancer Institute and a program project grant from the National Institute of Environmental Health Sciences. Dr. Thomas works closely with the UNC Lineberger Comprehensive Cancer Center as well.

• These researchers are interested in elucidating melanoma heterogeneity and its relationship to risk, diagnosis, and survival. In the population-based Genes, Environment, and Melanoma Study, they are determining somatic BRAF and NRAS mutations in melanomas from several international sites and their associations with histopathologic features, environmental and genetic risk factors, and survival. • They are also investigating the interfaces between host characteristics, immunity, the environment, and tumor heterogeneity with the ultimate goal of applying this information towards improving prevention, prognostic models, and treatments for melanoma. • Furthermore, they are approaching melanoma diagnosis and heterogeneity through investigation of differential DNA methylation profiles between melanoma subtypes and benign nevi. • They are also collaborating with statisticians and computer scientists to develop novel image analysis methodology for melanoma classification and diagnosis.

Make an Appointment

Call 984-974-3900 for an appointment

  • Access My UNC Chart
  • Patient Care Information
  • UNC Chapel Hill

Thomas, Conway-Dorsey Labs Receive $4.6 Million NCI Grant to Study Melanoma Mortality

May 27, 2020

By Emma Beckham

Drs. Nancy Thomas and Kathleen Conway-Dorsey

The National Cancer Institute has awarded UNC Lineberger’s Nancy E. Thomas, MD, PhD, and her collaborators at University of North Carolina, Memorial Sloan Kettering, University of New Mexico, and University of California at Irvine a $4.6-million grant to study the Identification of Lethal Melanomas at the Time of Diagnosis .

Melanoma is an aggressive malignancy with high metastatic propensity that can be life-threatening for certain patients. The plan is to evaluate the genetic and immune alterations in tumor samples and host characteristics associated with a high risk of melanoma lethality. The goal is to identify at the time of diagnosis which melanomas are the dangerous, potentially lethal ones that should be treated early and, conversely, which melanomas are very unlikely to lead to recurrence and death, potentially sparing these patients toxic and expensive treatments.

The work will be done in the labs of Nancy Thomas, chair of the UNC Department of Dermatology and the Irene and Robert Alan Briggaman Distinguished Professor, and Kathleen Conway-Dorsey, PhD, associate professor of epidemiology at the UNC Gillings School of Global Public Health and a UNC Lineberger member.

Other UNC collaborators are Paul Googe, MD, professor of dermatology and pathology and laboratory Medicine, David Ollila, MD, professor of surgery, Joel Parker, PhD, associate professor of genetics, and Nana Nikolaishvili-Feinberg, PhD, director of the Translational Pathology Laboratory. Lab members instrumental to the research are Sharon Edmiston, Eloise Parrish, and Honglin Hao. Ollila and Parker are UNC Lineberger members.

Filed Under:

More from Newsroom

  • Five Questions with Blair Byrd
  • UNC School of Medicine Ranks 6th in NIH Funding for Public Universities
  • Newsworthy from the School of Medicine, Week of February 16 – February 22

Select Year:

provider's profile picture

Dr. Nancy E. Thomas, MD

(No ratings)

Dr. Nancy E. Thomas, MD is a dermatologist in Chapel Hill, NC specializing in dermatology (skin disorders) and general practice. She graduated from Weill Cornell Medical College in 1987 and has 37 years of experience. Dr. Nancy E. Thomas, MD is affiliated with UNC PHYSICIANS AND ASSOCIATES.

In The News  (see more mentions in the news)

Medicare procedure and patient information, 2013 medicare procedure volume.

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2013 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and .

Volume of procedures performed by Dr. Nancy E. Thomas, MD for Medicare patients.

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Nancy E. Thomas, MD.

Conditions of Medicare patients treated by Dr. Nancy E. Thomas, MD in 2013

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2013 were Hypertension, High Cholesterol, Diabetes and Depression.

2014 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2014 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and hospital care.

2014 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2014.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2014 were Hypertension, High Cholesterol, Diabetes and Depression.

2015 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2015 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and .

2015 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2015.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2015 were Hypertension, High Cholesterol, Depression and Diabetes.

2016 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2016 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and .

2016 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2016.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2016 were Hypertension, High Cholesterol, Diabetes and Depression.

2017 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2017 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and .

2017 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2017.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2017 were Hypertension, High Cholesterol, Ischemic Heart Disease and Chronic Kidney Disease.

2018 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2018 were removal of lesion (e.g. growth), skin procedures, diagnostic procedures and .

2018 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2018.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2018 were Hypertension, High Cholesterol, Ischemic Heart Disease and Chronic Kidney Disease.

2019 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2019 were removal of lesion (e.g. growth), skin procedures, and .

2019 Medicare Patient Data

Conditions of medicare patients treated by dr. nancy e. thomas, md in 2019.

The most common conditions of Medicare patients that Dr. Nancy E. Thomas, MD treated during 2019 were Hypertension, High Cholesterol, Ischemic Heart Disease and Chronic Kidney Disease.

2020 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2020 were removal of lesion (e.g. growth), skin procedures, and .

2021 Medicare Procedure Volume

The top procedures that Dr. Nancy E. Thomas, MD treated as a dermatologist in Chapel Hill, NC during 2021 were removal of lesion (e.g. growth), skin procedures, and .

Education & Training

Dr. Nancy E. Thomas, MD graduated from Weill Cornell Medical College in 1987. She has a state license in North Carolina.

Medical School: Weill Cornell Medical College

Licensed In: North Carolina

Affiliations & Hospitals

Dr. Nancy E. Thomas, MD is associated with these hospitals and organizations:

Insurance Information

Dr. Nancy E. Thomas, MD appears to accept the following insurance providers: Contigo Health, Humana, WellCare, AmeriHealth Caritas, Carolina Complete Health, Veterans Affairs, UnitedHealthcare, Cigna, MedCost, BlueCross BlueShield of North Carolina (BCBSNC), Aetna and Liberty Advantage.

According to our sources, Dr. Nancy E. Thomas, MD accepts the following insurance providers:

Ratings & Reviews

Dr. Nancy E. Thomas, MD does not have any reviews yet, be the first to leave a review of Dr. Nancy E. Thomas, MD here:  Leave a Review

General Payments

These charts describe general payments received by Dr. Nancy E. Thomas, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Dr. Nancy Thomas' areas of specialization are general practice and dermatology (skin disorders); she sees patients in Chapel Hill, NC. After completing medical school at Weill Cornell Medical College, Dr. Thomas performed her residency at Strong Memorial Hospital. She accepts several insurance carriers, including BlueCross BlueShield of North Carolina, UnitedHealthcare, and Blue California. She is affiliated with UNC Health Care. According to Yext, she is not acceping new patients at this time.

Dermatologists in Nearby Locations

Other providers in chapel hill, nc.

Logo

  • Website Management
  • Listing Management
  • Social Media
  • Digital Advertising
  • Content Marketing
  • Reputation Management
  • Online Appointments

Nancy E. Thomas, MD, PhD

410 Market St., Chapel Hill, NC, 27516, USA

8:00AM - 5:00PM

Patient reviews of Nancy E. Thomas, MD, PhD

WRITE A REVIEW

FAQs about Nancy E. Thomas, Md, Ph D

Is nancy e. thomas, md, phd accepting new patients.

Nancy E. Thomas, MD, PhD generally accepts new patients.

Does Nancy E. Thomas, MD, PhD provides tele-medicine services?

Nancy E. Thomas, MD, PhD has not indicated on the profile that their office offers tele-health visits. You can call their office to find out more about telehealth visits.

Does Nancy E. Thomas, MD, PhD offer same day appointments?

Nancy E. Thomas, MD, PhD has not indicated on the profile that their office offers same day appointments. You can call their office to find out more about same day appointments.

How can I make appointment with Nancy E. Thomas, MD, PhD?

You can request appointment via HealthSoul or contact their office.

What modes of payment are accepted by office of Nancy E. Thomas, MD, PhD?

You can make payment via cash, credit card or debit card.

What is office location of Nancy E. Thomas, MD, PhD?

The office is located at 410 Market St. in Chapel Hill, NC.

Does Nancy E. Thomas, MD, PhD accepts my insurance?

Nancy E. Thomas, MD, PhD accepts various types of health insurance, but individual coverage may be variable. You should check with your health insurance whether the particular doctor is in network or not.

HEALTHCARE Q&A

Do You Have Questions About Healthcare? ASK A QUESTION

Reasons Why Workers Compensation is a Must-Have for Businesses

Exploring tooth extractions - procedure and recovery, featured doctor, aaron hervey.

Make an Appointment - (919) 933-2000

Aaron J. Miller, MD

Internal Medicine

Make an Appointment - 9842154340

Aaron Lemmon

Certified Registered Nurse Anesthetist

Make an Appointment - (919) 966-6759

Best hospitals near you

  • Los Angeles
  • San Francisco

Find More Specialists In Your Area

  • Chiropractic
  • Cardiologists
  • Dermatologists
  • Massage Therapist
  • Nephrologists
  • Neurologists
  • Oncologists
  • Pediatrician
  • Family Medicine

You Are Requesting An Appointment With Nancy E. Thomas, MD, PhD

To request an appointment, choose to call the office directly or fill out the request form below.

Doctor Phone

Appointment information.

Your information will be shared with the office you are requesting appointment with and stored in your user profile

Privacy Policy

As part of my use of HealthSoul, I acknowledge the use of my information will be processed in accordance with the HealthSoul Privacy Policy and Terms of Service. By clicking "Accept", I am hereby providing consent to this use and agree to all of the terms and conditions.

  • UNC Chapel Hill

UNC Lineberger

Meet the faculty and staff who work with the UNC Skin Cancer and Melanoma Program.

David Ollila

David Ollila

MD Distinguished Professor UNC-Chapel Hill

Nancy E. Thomas

Nancy E. Thomas

MD, PhD Distinguished Professor UNC-Chapel Hill

Program Assistant

  • Patricia Roten, Surgical and Medical Oncology

Dermatology

  • Nancy Thomas, MD, PhD, Director
  • Bradley Merritt, MD
  • Jayson Miedema, MD
  • Paul Googe, MD, Dermatopathology
  • Puneet Jolly, MD, PhD

Medical Oncology

Frances Collichio

Frances Collichio

MD Professor UNC-Chapel Hill

Headshot of Carrie Lee.

MD, MPH Professor; Medical Director, UNC Lineberger Clinical Protocol Office; Chief Medical Officer, UNC Lineberger Clinical Research UNC-Chapel Hill

Stergios Moschos

Stergios Moschos

MD Associate Professor UNC-Chapel Hill

Headshot of Jonathan Sorah.

Jonathan Sorah

MD Assistant Professor UNC-Chapel Hill

Plastic and Reconstructive Surgery

Lynn Ann Damitz

Lynn Ann Damitz

Radiology/nuclear medicine.

  • Lauren Burke, MD, FSAR
  • Amir Khandani, MD

Surgical Oncology

Patricia Long

Patricia Long

MSN, RN, FNP-C Melanoma UNC-Chapel Hill

Michael Meyers

Michael Meyers

Headshot of Karyn Stitzenberg.

Karyn B. Stitzenberg

MD, MPH, FACS Professor UNC-Chapel Hill

Headshot of Jen Jen Yeh

Jen Jen Yeh

MD Professor; Director, UNC Lineberger Pancreatic Cancer Center of Excellence UNC-Chapel Hill

Radiation Oncology

Headshot of Xuguang Scott Chen

Xuguang Scott Chen

MD, PhD Assistant Professor UNC-Chapel Hill

Nutritionist

  • Mandy Holliday, MPH, RD, LDN, CNSC

Nurse Navigator

  • Paula Landman, RN, MSN

Clinical Trials Office

The Clinical Trials Office (CTO) supports the design and conduct of oncology clinical trials. The CTO is responsible for patient and study coordination-related activities, including subject evaluation and registration, toxicity assessment and safety monitoring of novel therapeutics and patient education.

The CTO works to assure patient eligibility and safety, regulatory compliance, and quality, reproducible data.

Learn more about the  UNC Lineberger Clinical Trials Office  

Logo

21 Feb Genetics Study Points To Different Pathways For Melanoma Risk

MedicalResearch.com Interview with:

Nancy E. Thomas, MD PhD Department of Dermatology, University of North Carolina Chapel Hill, NC 27599

Dr. Nancy E. Thomas

Nancy E. Thomas, MD PhD Department of Dermatology, University of North Carolina Chapel Hill, NC 27599

Medical Research: What is the background for this study?

Dr. Thomas : Melanoma had been thought for some time to arise from at least two causal pathways, a ‘chronic sun exposure pathway’ and a ‘nevus pathway’. However, the role of inherited genetic variation in development of melanoma along these pathways had not previously been studied. Thus, we chose to examine the association of SNPs in putative low-penetrance melanoma susceptibility loci with histologic markers of divergent pathways .

Medical Research: What are the main findings? Dr. Thomas : Within the large Genes, Environment and Melanoma Study, we investigated the relationship of germline variants in newly identified low-penetrance melanoma risk loci to histologic markers of divergent causal pathways in melanoma. We present strong evidence that the  IRF4  rs12203592*T genotype is positively associated with chronic sun exposure-related melanoma and inversely associated with nevus-related melanoma. We also found that the  IRF4  rs12203592 genotype is linked to the bi-model age distribution known to occur in melanoma and which is related to the divergent pathways.  IRF4  rs12203592 is a functional variant known to affect  IRF4  expression in human skin and melanoma cell lines. We conclude that  IRF4 rs12203592 is likely, at least in part, to determine pathway-specific risk for melanoma development.

Medical Research: What should clinicians and patients take away from your report?

Dr. Thomas : This is the first study to our knowledge that provides evidence that inherited genetic variation likely underlies susceptibility to divergent pathways in melanoma development.  In other words, you could be more susceptible to one type of melanoma if you have one particular genotype of IRF4 and more susceptible to another type of melanoma if you have the other genotype of IRF4. One’s IRF4 genotype could also determine the likelihood that melanoma would arise earlier or later in life. Understanding risk factors for different types of melanoma could lead to distinct prevention opportunities.

Medical Research: What recommendations do you have for future research as a result of this study?

Dr. Thomas : Our results characterize the association of inherited melanoma-associated SNPs with histopathological markers of the divergent pathways (solar elastosis and neval remnants).  Further work needs to be done to determine the associations of inherited SNPs with molecular markers of divergent pathways such as DNA driver mutations in the  BRAF  and  NRAS  oncogenes and alterations in tumor suppressor genes.

It is highly likely that the full spectrum of risk factors for melanoma has not yet been identified and some risk factors may only be identified through study of divergent pathways. Mounting evidence suggests that melanoma is a heterogeneous disease with distinct etiologic pathways, and this has likely been a barrier to the discovery of new risk loci. If associations are opposite for the different pathways as we found for  IRF4 rs12203592 then they may not be identified in studies that combine melanomas that formed along different pathways.  We speculate in the paper that this could be why  IRF4  rs12203592 has been inconsistently associated with melanoma risk in different studies.

Future research should be conducted to clarify the etiologically distinctive melanoma subtypes and use the results to both refine our search of new risk factors and develop more accurate risk prediction tools for these distinctive subtypes.

Medical Research: Is there anything else you would like to add?

Dr. Thomas : We chose 47 single-nucleotide polymorphisms (SNPs) within 21 genetic loci previously reported to be in associated with melanoma in other studies. Since our work has been initiated, additional SPNs have been found to be associated with melanoma and fine mapping has been done of some of the loci to identify the most strongly associated SNPs.  These additional SNPs warrant examination in relationship to markers of divergent pathways in further similar analyses.

David C. Gibbs, Irene Orlow, Jennifer I. Bramson, Peter A. Kanetsky, Li Luo,Anne Kricker, Bruce K. Armstrong, Hoda Anton-Culver, Stephen B. Gruber,Loraine D. Marrett, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso,Terence Dwyer, Ajay Sharma, Emily La Pilla, Lynn From, Klaus J. BusamAnne E. Cust, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas,and on behalf of the GEM Study Group

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways JNCI J Natl Cancer Inst (2016) 108 (7): djw004 doi:10.1093/jnci/djw004 First published online February 8, 2016 (9 pages)

[wysija_form id=”5″]

Nancy E. Thomas, MD PhD (2016). Genetics Study Points To Different Pathways For Melanoma Risk 

Last Updated on February 21, 2016 by Marie Benz MD FAAD

Privacy Overview

  • Specialists Cardiologists Chiropractors Dermatologists ENT Doctors Eye Doctors Family Doctors Get Listed » Internists Massage Naturopaths OBGYN Oncologists Pediatricians Physical Therapists Podiatrists Surgeons Urologists Search by Name More Specialists > Healthy Living Dietitians Fitness Health Food Salons Spas Yoga Dental Health Dentists Oral Surgeons Orthodontists Providers A-Z # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Mental Health Counselors Psychiatrists Psychologists Senior Care Assisted Living Hospice Nursing Homes Other Animal Hospitals Hospitals Medical Supplies Pharmacies Veterinarians
  • Health Allergies Conditions Diagnostics Therapies Lifestyle Beauty Diet Fitness Health Nutrition Food Herbs Recipes Vitamins Wellness Features What Is Wellness? Wellness News Featured Articles Wellness Extras Discount Health Benefits Product Sponsors Insurance Health Insurance Life Insurance
  • Interact Blogs Goals Members Podcasts Contribute Write For Us List Your Business Publishing Rules Join Featured Contributors Featured Authors Featured Providers Horoscopes Daily Horoscope
  • Sign Up Free | Log In
  • Phone Numbers & Directions

Nancy Thomas, MD, PHD

Dermatologists.

nancy e. thomas md phd chapel hill reviews

Aida Lugo-Somolinos, MD

Chapel hill, nc.

nancy e. thomas md phd chapel hill reviews

Allison C. Weis, PA-C, MPH

nancy e. thomas md phd chapel hill reviews

Bradley G. Merritt, MD

nancy e. thomas md phd chapel hill reviews

Dermatologist

IMAGES

  1. Dr. Nancy Thomas, MD

    nancy e. thomas md phd chapel hill reviews

  2. Immunotherapy for lung and other cancers may also be beneficial for

    nancy e. thomas md phd chapel hill reviews

  3. Examen quinquennal en cours pour Nancy E. Thomas, MD, PhD, professeure

    nancy e. thomas md phd chapel hill reviews

  4. Nancy E. Hill

    nancy e. thomas md phd chapel hill reviews

  5. Dr. Nancy N. Thomas, MD

    nancy e. thomas md phd chapel hill reviews

  6. Rachel Thomas, MD, PhD

    nancy e. thomas md phd chapel hill reviews

COMMENTS

  1. Dr. Nancy E. Thomas, MD

    Overview Dr. Nancy E. Thomas is a dermatologist in Chapel Hill, North Carolina and is affiliated with UNC Hospitals. She received her medical degree from Weill Cornell Medicine and has...

  2. Dr. Nancy Thomas, MD

    Practice. Office 410 Market St Ste 400 Chapel Hill, NC 27516. Dr. Nancy Thomas, MD is a dermatologist in Chapel Hill, NC and has over 36 years of experience in the medical field. She graduated from CORNELL UNIVERSITY / NEW YORK STATE STATUTORY COLLEGES in 1987. Her office accepts new patients.

  3. Dr. Nancy E. Thomas

    2 COMMENTS 1 SPECIALTY 1 BOARD CERTIFICATION 1 LOCATION Patients' Perspective On-time appointments Good bedside manner Based on patient feedback. Read the reviews Ratings Overview 4 8 Ratings Write a Review

  4. Dr. Nancy Thomas, Dermatology

    Dr. Nancy Thomas, is a Dermatology specialist practicing in Chapel Hill, NC with undefined years of experience. This provider currently accepts 12 insurance plans. New patients are welcome and they also offer telehealth appointments.

  5. Nancy Thomas, MD, PhD

    Administration. 3122 Neuroscience Research Bldg. 115 Mason Farm Road, CB#7287 Chapel Hill, NC 27599-7287 Telephone: 919-966-0785 Fax: 919-966-3898

  6. Dr. Nancy E. Thomas, MD, PhD

    Overview Dr. Nancy Thomas, MD, PhD is a Dermatologist (Skin Specialist), who primarily practices in Chapel Hill, NC. She has been practicing for over 29 years and is board certified...

  7. Dr. Nancy Thomas, MD

    Summary Dr. Nancy Thomas is a dermatologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. She received her medical degree from Weill Cornell Medical College of Cornell University and has been in practice 30 years. She is experienced in melanoma and cutaneous malignancies and complex medical dermatology.

  8. Nancy E. Thomas, MD, PhD

    Nancy E. Thomas, MD, PhD is affiliated with UNC Health and specializes in Dermatology in Chapel Hill, NC.

  9. Nancy Thomas, MD, PhD Laboratories

    Nancy Thomas, MD, PhD Laboratories ... Studies described are carried out in the laboratories of Dr. Nancy Thomas and her collaborators in the Melanoma Multidisciplinary Group at UNC and the Genes, Environment, and Melanoma Group (GEM). ... Chapel Hill, NC 27516 Telephone: 984-974-3900 Fax: 984-974-3692. Administration.

  10. Thomas, Conway-Dorsey Labs Receive $4.6 Million NCI Grant to ...

    Drs. Nancy Thomas and Kathleen Conway-Dorsey. The National Cancer Institute has awarded UNC Lineberger's Nancy E. Thomas, MD, PhD, and her collaborators at University of North Carolina, Memorial Sloan Kettering, University of New Mexico, and University of California at Irvine a $4.6-million grant to study the Identification of Lethal Melanomas at the Time of Diagnosis.

  11. Utility of TERT Promoter Mutations for Cutaneous Primary... : The

    Correspondence: Nancy E. Thomas, MD, PhD, Department of Dermatology, University of North Carolina, 2159 Genomic Science Building, CB#7287, Chapel Hill, NC 27599 (e-mail: [email protected]). This work was funded by the National Cancer Institute grants R21CA134368, R33CA160138, R03CA199487 to K. Conway and N.E. Thomas, P01CA206980 to M. Berwick ...

  12. Nancy Thomas Dermatologist in Chapel Hill, NC

    Nancy Thomas is a Dermatologist in Chapel Hill, NC. Read reviews, contact information, driving directions and get the phone number for Nancy Thomas. ... Nancy E. Thomas, MD, PhD Office (984) 974-3900 Fax (984) 974-3692 410 Market St. Suite 400A Chapel Hill, NC 27516. Visit Our Website.

  13. Nancy E. Thomas, MD

    Dr. Nancy Thomas is a dermatologist in Chapel Hill, NC. She diagnoses, treats, and manages skin problems, as well as those of the hair & nails. Reviews of Dr. Thomas

  14. BRAF somatic mutations in malignant melanoma and melanocytic

    REVIEW. BRAF somatic mutations in malignant melanoma and melanocytic naevi. Thomas, Nancy E. ... North Carolina, USA. Correspondence and requests for reprints to Nancy E. Thomas MD, PhD, Department of Dermatology, University of North Carolina, 3100 Thurston Bowles Building, CB♯7287, Chapel Hill, NC 27599, USA. Tel: 1-919-966-0785; fax: 1-919 ...

  15. Dr. Nancy E. Thomas, MD, PhD

    Procedure Volume Patient Data Patient Conditions Reviews General Payments Back ... Weill Cornell Medical College (1987) 410 Market Street Suite 400 Chapel Hill, NC 27516 (984) 974-3900. Dr. Nancy E. Thomas, MD, PhD is a dermatologist in Chapel Hill, NC specializing in dermatology (skin disorders). She graduated from Weill Cornell Medical ...

  16. Nancy E. Thomas, MD, PhD, in Chapel Hill

    Nancy E. Thomas, MD, PhD practices in Chapel Hill, NC - USA. You can find the phone number, practice website, location and reviews of Nancy E. Thomas, MD, PhD on healthsoul.com. Find more informat...

  17. Who We Are

    Distinguished Professor UNC-Chapel Hill Nancy E. Thomas MD, PhD Distinguished Professor UNC-Chapel Hill Program Assistant Patricia Roten, Surgical and Medical Oncology Dermatology Nancy Thomas, MD, PhD, Director Bradley Merritt, MD Jayson Miedema, MD Paul Googe, MD, Dermatopathology Puneet Jolly, MD, PhD Medical Oncology Frances Collichio MD

  18. DR. NANCY E THOMAS MD, NPI 1295845907

    Dermatology NPI Profile 1295845907 DR. NANCY E THOMAS MD NPI 1295845907 Dermatology in Chapel Hill, NC NPI Status: Active since August 30, 2006 Contact Information 101 MANNING DR CHAPEL HILL, NC ZIP 27599 Phone: (919) 966-4996 Fax: (919) 843-5515 Get Directions Reviews NPI Profile NPI Record Similar Providers Nearby Table of Contents Individual

  19. Genetics Study Points To Different Pathways For Melanoma Risk

    MedicalResearch.com Interview with: Nancy E. Thomas, MD PhD Department of Dermatology, University of North Carolina Chapel Hill, NC 27599 Medical

  20. Nancy E. Thomas, MD, PhD in Chapel Hill, NC 27516

    Nancy E. Thomas, MD, PhD located at 410 Market St., Chapel Hill, NC 27516 - reviews, ratings, hours, phone number, directions, and more.

  21. Nancy E. Thomas, MD, PhD

    Detailed profile of Nancy E. Thomas, MD, PhD, a Dermatologist (Skin Specialist) - General Chapel Hill NC. See insurances she accepts. Read ratings and reviews from other patients.

  22. Nancy Thomas, MD, PHD Dermatologist in Chapel Hill, NC

    Nancy Thomas, MD, PHD is a Dermatologist in Chapel Hill, NC. Read reviews, contact information, driving directions and get the phone number for Nancy Thomas, MD, PHD. Directory. Specialists Cardiologists Chiropractors Dermatologists ENT Doctors Eye Doctors Family Doctors.